Succesful Treatment of a Patient with Retinal Arterial Macroaneurysm with İntravitreal Ranibizumab Injection: Case Report

Purpose: To present the effect of intravitreal ranibizumab (Lucentis®) therapy in a patient suffering from symptomatic retinal arterial macroaneurysm. Methods: Case report. A 67-year-old female patient was diagnosed with retinal macroaneurysm of the superior temporal artery with serous macular detachment and hemorrhage Intravitreal montly three 3 injection of ranibizumab was initiated to the patient. Her best-corrected visual acuity and morphological data were evaluated by optical coherence tomography and fluorescein angiography. Results: Best-corrected visual acuity improved from 1/10 at baseline to 3/10 at 3-month follow-up and maintained stable throught 12 month. Central retinal thickness measured by optical coherence tomography decreased from 678 μm at baseline to 248 μm with the resolution of serous detachments after the 3rd injection. Almost complete reabsorption of the hard exudates was also observed after the 3rd injection. Conclusion: Intravitreal ranibizumab injection may be effective in the treatment of serous macular detachment associated with retinal macroaneurysms.